← Back to Glossary← Back to Glossary
F
Folding Intermediate Characterisation
Biopharmaceutical Glossary
Folding intermediate characterisation identifies protein species formed during refolding from denatured states. Chaperone protein assistance guides correct folding pathways. Misfolded intermediates aggregating create insoluble species. Kinetic folding studies track structural development. NMR spectroscopy provides residue-level structural information.
Production optimisation prevents misfolding reducing waste. Biophysical characterisation confirms proper folding. Regulatory submissions justify folding processes producing therapeutic proteins. Quality control monitors folding consistency. Emerging technologies enhance folding efficiency.
